Uncategorised - European Medical Journal

Genetic Discovery Unlocks Epilepsy Treatments with Repurposed Cancer Drugs

Discovery of DYRK1A and EGFR mutations advances personalised epilepsy care, offering diagnostic biomarkers and repurposed drug opportunities.

Urinary Microbiome of Patients with Spina Bifida Influences UTI Risk

New research provides valuable insights into the urinary and intestinal microbiomes of individuals with spina bifida, a condition associated with an increased risk for UTIs.

Innovative Valve Treatment Shows Potential for Patients With Emphysema

Combined valve implantation in the right upper and middle lobes shows promise for severe emphysema, with significant benefits for heterogeneous cases.

High-Risk Women with BRCA Mutations Often Denied Breast MRI

Novel research has shown that women are frequently denied MRI scans, despite usual recommendations.

5-Year Outcomes of Valve Type and Anaesthesia Strategy for TAVR

SEV and BEV valves with CS or GA yield similar TAVR outcomes; CS lowers mortality and SEVs reduce stroke risk.

mRNA-Based T-Cell Therapy Offers Safer, More Affordable Cancer Treatment

A new study has introduced an innovative approach to CAR-T therapy that could address some of the current challenges in cancer treatment…

Oral Medication for Gestational Diabetes Less Effective Than Insulin

Research has found that oral medication is less effective than insulin for gestational diabetes.

Improving Anaphylaxis Diagnosis with Trigger-Specific Findings

Trigger-specific patterns in anaphylaxis improve diagnosis and treatment, reducing delays in life-saving emergency care.

Advancing Precision Immunotherapy for Stage II Melanoma

A recent study has uncovered promising advancements in the fight against Stage II melanoma by introducing a novel biomarker technique, immune Förster resonance energy transfer (iFRET).

Medication-Free Remission in Juvenile Dermatomyositis

Achieving medication-free remission (MFR) is a critical milestone in the treatment of juvenile dermatomyositis (JDM), a rare inflammatory disease primarily affecting skin and muscles.